HITI
NASDAQ · Pharmaceuticals
High Tide Inc
$2.70
-0.11 (-3.91%)
Financial Highlights (FY 2026)
Revenue
935.46M
Net Income
-79,918,007
Gross Margin
26.0%
Profit Margin
-8.5%
Rev Growth
+18.5%
D/E Ratio
1.25
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 26.0% | 26.0% | 62.2% | 62.2% |
| Operating Margin | -3.4% | -3.1% | 14.1% | 13.8% |
| Profit Margin | -8.5% | -8.1% | 13.6% | 12.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 935.46M | 789.35M | 117.29M | 114.78M |
| Gross Profit | 243.13M | 205.15M | 73.00M | 71.43M |
| Operating Income | -31,899,230 | -24,225,218 | 16.56M | 15.79M |
| Net Income | -79,918,007 | -60,692,098 | 15.94M | 14.39M |
| Gross Margin | 26.0% | 26.0% | 62.2% | 62.2% |
| Operating Margin | -3.4% | -3.1% | 14.1% | 13.8% |
| Profit Margin | -8.5% | -8.1% | 13.6% | 12.5% |
| Rev Growth | +18.5% | +18.5% | +17.8% | -7.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 97.20M | 97.20M | 135.37M | 127.81M |
| Total Equity | 77.52M | 77.52M | 102.75M | 99.11M |
| D/E Ratio | 1.25 | 1.25 | 1.32 | 1.29 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 6.38M | 5.11M | 20.19M | 19.55M |
| Free Cash Flow | — | — | 10.06M | 12.39M |